Novatio Ventures
Novatio Ventures accelerates the commercialization of high-potential, high-impact life science innovations. Based in Toronto, Boston, and Hong Kong, it focuses on early-stage innovations from various markets, providing seed funding and active support to inventors, entrepreneurs, and institutions to develop and commercialize their technologies. The company aims for early exits with attractive, risk-mitigated financial returns, leveraging its global experience and network.
Industries
Nr. of Employees
small (1-50)
Novatio Ventures
First Canadian Place, 100 King Street West, Suite 5700 Toronto, Ontario M5X 1C7, Canada | One Broadway, 14th Floor Cambridge, MA 02142, U.S.A.
Services
Provide direct seed funding and advise on optimal fundraising strategies for early-stage life science innovations.
Advise on entity structure and provide interim executive and operational management to establish development plans and accelerate progress to milestones.
Originate and execute licensing and partnership deals, perform partner screening, and lead deal structuring, valuation and negotiations to monetize technologies.
Provide direct seed funding and advise on optimal fundraising strategies for early-stage life science innovations.
Advise on entity structure and provide interim executive and operational management to establish development plans and accelerate progress to milestones.
Originate and execute licensing and partnership deals, perform partner screening, and lead deal structuring, valuation and negotiations to monetize technologies.
Expertise Areas
- Preclinical development and translation
- Biomarker discovery and management
- Molecular diagnostics and proteomics
- Immunotherapy translational research
Key Technologies
- Genomics
- Biomarker discovery
- Molecular diagnostic assays
- Proteomics
News & Updates
Ontario Genomics invests in renewable chemicals.
7D Surgical receives FDA 510(k) and Health Canada MDL clearance for its breakthrough image guidance system for spine surgery.
Frank Rudzicz of Winterlight Labs was quoted in Wired Magazine.
Winterlight Labs secures seed funding to commercialize speech-based detection of cognitive impairments.
Western drives the launch of Precision Proteomics with new medical technology.
Ontario Genomics invests in renewable chemicals.
7D Surgical receives FDA 510(k) and Health Canada MDL clearance for its breakthrough image guidance system for spine surgery.
Frank Rudzicz of Winterlight Labs was quoted in Wired Magazine.
Winterlight Labs secures seed funding to commercialize speech-based detection of cognitive impairments.
Western drives the launch of Precision Proteomics with new medical technology.